{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Sensitivity&page=37", "query": { "condition": "Sensitivity", "page": 37 }, "page_size": 10 }, "pagination": { "page": 37, "page_size": 10, "total_count": 4803, "total_pages": 481, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Sensitivity&page=38&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Sensitivity&page=36&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-24T23:14:02.001Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05815758", "title": "Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Allergic Conjunctivitis" ], "interventions": [ { "name": "Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)", "type": "DRUG" }, { "name": "Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bausch & Lomb Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 512, "start_date": "2023-04-20", "completion_date": "2023-09-18", "has_results": true, "last_update_posted_date": "2025-07-10", "last_synced_at": "2026-10-24T23:14:02.001Z", "location_count": 7, "location_summary": "Chandler, Arizona • Havre de Grace, Maryland • Andover, Massachusetts + 4 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Havre de Grace", "state": "Maryland" }, { "city": "Andover", "state": "Massachusetts" }, { "city": "Apex", "state": "North Carolina" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT05815758" }, { "nct_id": "NCT01916226", "title": "A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Rhinitis, Allergic, Perennial and Seasonal" ], "interventions": [ { "name": "FPNS", "type": "DRUG" }, { "name": "FPNS Placebo", "type": "DRUG" }, { "name": "Cetirizine", "type": "DRUG" }, { "name": "Cetirizine Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 682, "start_date": "2013-08-01", "completion_date": "2013-10-17", "has_results": true, "last_update_posted_date": "2018-06-20", "last_synced_at": "2026-10-24T23:14:02.001Z", "location_count": 31, "location_summary": "Little Rock, Arkansas • Denver, Colorado • Aventura, Florida + 27 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Denver", "state": "Colorado" }, { "city": "Aventura", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01916226" }, { "nct_id": "NCT00604578", "title": "Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat Asthma", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma", "Airway Inflammation", "Airflow Obstruction", "Airway Hyperactivity" ], "interventions": [ { "name": "Pioglitazone Hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 0, "start_date": "2008-01-04", "completion_date": "2009-10-30", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-10-24T23:14:02.001Z", "location_count": 2, "location_summary": "Bethesda, Maryland • Falls Church, Virginia", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Falls Church", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00604578" }, { "nct_id": "NCT01092143", "title": "BI 671800 ED in Steroid-naive Asthmatic Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "BI 671800", "type": "DRUG" }, { "name": "Fluticasone propionate placebo", "type": "DRUG" }, { "name": "Fluticasone propionate", "type": "DRUG" }, { "name": "BI 671800 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 389, "start_date": "2010-03-18", "completion_date": "2011-03-26", "has_results": true, "last_update_posted_date": "2022-05-31", "last_synced_at": "2026-10-24T23:14:02.001Z", "location_count": 40, "location_summary": "Tucson, Arizona • Cypress, California • Los Angeles, California + 34 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Cypress", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palmdale", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01092143" }, { "nct_id": "NCT00920543", "title": "GSK BHR Study (Sont)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "FP 100mcg", "type": "DRUG" }, { "name": "FP 500mcg", "type": "DRUG" }, { "name": "FP 250mcg", "type": "DRUG" }, { "name": "FSC 100/50mcg", "type": "DRUG" }, { "name": "FSC 250/50mcg", "type": "DRUG" }, { "name": "FSC 500/50mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 464, "start_date": "2003-02", "completion_date": "2004-10", "has_results": false, "last_update_posted_date": "2016-09-01", "last_synced_at": "2026-10-24T23:14:02.001Z", "location_count": 52, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Carmichael", "state": "California" }, { "city": "Palmdale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00920543" }, { "nct_id": "NCT00621530", "title": "Effect of Spinal Ketorolac on Mechanical Hypersensitivity After a Total Hip Replacement", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hip Arthroplasty" ], "interventions": [ { "name": "ketorolac tromethamine opthalmic solution", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 62, "start_date": "2008-03", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2018-09-11", "last_synced_at": "2026-10-24T23:14:02.001Z", "location_count": 2, "location_summary": "Winston-Salem, North Carolina • Cleveland, Ohio", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00621530" }, { "nct_id": "NCT07190300", "title": "TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)" ], "interventions": [ { "name": "Tulmimetostat", "type": "DRUG" }, { "name": "Darolutamide", "type": "DRUG" }, { "name": "Abiraterone", "type": "DRUG" }, { "name": "Prednisone/Prednisolone", "type": "DRUG" }, { "name": "Androgen Deprivation Therapy (ADT)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 181, "start_date": "2026-01-13", "completion_date": "2032-08-02", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-24T23:14:02.001Z", "location_count": 8, "location_summary": "Birmingham, Alabama • Iowa City, Iowa • Westwood, Kansas + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Westwood", "state": "Kansas" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07190300" }, { "nct_id": "NCT00860834", "title": "Telephone Coaches to Improve Control of Asthma in Children ( PARTNER) Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Asthma Coaching Program", "type": "BEHAVIORAL" }, { "name": "Usual Care", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "3 Years to 12 Years" }, "enrollment_count": 984, "start_date": "2008-08", "completion_date": "2014-05-03", "has_results": false, "last_update_posted_date": "2018-10-03", "last_synced_at": "2026-10-24T23:14:02.001Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00860834" }, { "nct_id": "NCT00895921", "title": "Examining the Effects of Antipsychotic Medications on Insulin Sensitivity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetes" ], "interventions": [ { "name": "Olanzapine", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Veterans Medical Research Foundation", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "65 Years", "sex": "MALE", "summary": "40 Years to 65 Years · Male only" }, "enrollment_count": 30, "start_date": "2008-11", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2020-08-11", "last_synced_at": "2026-10-24T23:14:02.001Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00895921" }, { "nct_id": "NCT00041821", "title": "Nasal Irritation Study: Individual Factors in Nasal Irritant Sensitivity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rhinitis, Allergic, Nonseasonal" ], "interventions": [ { "name": "Nasal irritation thresholds and irritant provocation", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "National Institute of Environmental Health Sciences (NIEHS)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "18 Years to 69 Years" }, "enrollment_count": 64, "start_date": "2000-09", "completion_date": null, "has_results": false, "last_update_posted_date": "2006-03-23", "last_synced_at": "2026-10-24T23:14:02.001Z", "location_count": 1, "location_summary": "Richmond, California", "locations": [ { "city": "Richmond", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00041821" } ] }